AMGEN INC Annual Nonoperating Income (Expense) in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Amgen Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Amgen Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.83B, a 167% increase year-over-year.
- Amgen Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.69B, a 28.5% decline year-over-year.
- Amgen Inc annual Nonoperating Income (Expense) for 2023 was $2.83B.
- Amgen Inc annual Nonoperating Income (Expense) for 2022 was -$814M, a 414% decline from 2021.
- Amgen Inc annual Nonoperating Income (Expense) for 2021 was $259M, a 1.17% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)